Core Laboratories earnings date
Core Laboratories (CLB) Q3 2026 Earnings Report
MX:CLB Q3 2026 EPS Results
- Actual EPS
- MXN 3.01
- Consensus EPS
- MXN 3.01
- Beat/Miss
- Met expectations
- One Year Ago EPS
- MXN 4.13
MX:CLB Q3 2026 Revenue Results
- Actual Revenue
- MXN 2.48B
- Expected Revenue
- MXN 2.48B
- Beat/Miss
- Beat by +MXN 3.95M
- YoY Revenue Growth
- -1.82%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/28/2026
- Time
- After Close
- Conference Call
- Wednesday, October 28, 2026
Core Laboratories's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
The call was balanced. Core Lab reported meaningful sequential improvements in revenue, operating income, margins, product sales and EPS, along with several technology wins, a 5-year contract and expectations for stronger global activity in 2027. However, geopolitical conflicts continued to depress year-over-year service and Reservoir Description results, reduce demand for crude assay work, delay projects, constrain cash flow and create uncertainty. Fourth-quarter revenue is expected to remain relatively flat, making the overall tone neutral despite management's constructive longer-term outlook.
For the fourth quarter 2026, Core Lab expects revenue to remain relatively flat sequentially; Reservoir Description revenue is projected to range from $81 million to $85 million with operating income of $5.1 million to $8.3 million, Production Enhancement revenue is estimated to range from $47.5 million to $49.5 million with operating income of $5.5 million to $6.7 million, and company revenue is projected to range from $128.5 million to $134.5 million with operating income of $10.7 million to $15.1 million, yielding operating margins of 10%, while EPS is expected to range from $0.12 to $0.20; guidance excludes gains and losses in foreign exchange and assumes an effective tax rate of 25%, 2026 G&A ex-items is expected to be approximately $43 million to $45 million, and full-year 2026 capital expenditures excluding CapEx for rebuilding the U.K. facility are expected to be in the range of $14 million to $16 million.
- Sequential Improvement in Overall Operating PerformanceCompared with the second quarter of 2026, operational performance improved with higher revenue, operating income, operating margins and earnings per share.
- Third-Quarter Revenue and EBIT Growth Versus Q2Third-quarter revenue was $132.1 million, up 6% sequentially. EBIT ex-items was $12.6 million, up from $9.4 million in the prior quarter, with an EBIT margin of approximately 10%, expanding 200 basis points sequentially.
- Reservoir Description Sequential RecoveryReservoir Description revenue was $84.3 million, up 7% from Q2 2026. Operating income ex-items increased to $8.1 million from $3.7 million, operating margins improved to 10% from 5%, and sequential incremental margins were 78%.
- Production Enhancement Revenue GrowthProduction Enhancement revenue was $47.8 million, up 4% sequentially and 3% year-over-year. Product sales improved in both U.S. land and international markets, reflecting continued operator adoption of Core Lab's advanced completion technologies.
- Strong Product Sales GrowthProduct sales were $36.1 million, up 19% sequentially and 8% year-over-year. International product sales increased 31% compared with the second quarter, and laboratory instrumentation sales were also higher sequentially.
- Service Revenue Increased SequentiallyService revenue was $96 million, up 2% sequentially. Demand for reservoir rock and fluid analytical programs increased in nearly all international regions, including the Middle East, while growth in other regions offset some of the geopolitical impact.
- Improved Manufacturing Cost PerformanceCost of sales ex-items improved to 83% of revenue from 85% in the prior quarter and 88% in the prior-year quarter. The sequential improvement was attributed to higher revenue, absorption of fixed costs, cost-control initiatives and manufacturing efficiencies.
- Net Income and EPS Improved SequentiallyNet income ex-items was $7.4 million, up from $5.1 million in Q2 2026. Diluted EPS ex-items was $0.16, compared with $0.11 in the prior quarter.
- Continued Shareholder ReturnsCore Lab returned free cash to shareholders through its quarterly dividend and repurchased approximately 88,000 shares for $1.1 million. The third quarter marked the eighth consecutive quarter of share buybacks.
- Technology Investment and Strategic ExecutionThe company continued executing its strategic plan of technology investments aimed at solving client problems and capitalizing on technical and geographic opportunities. Core Lab stated that it will continue introducing new product and service offerings, maintaining a lean and focused organization, and returning excess free cash while preserving its strong balance sheet.
- Carbon Capture and Storage Project in MalaysiaReservoir Description secured a carbon capture and storage project in Malaysia for a major international operator evaluating long-term CO2 injection into a depleted natural gas reservoir. The work includes reservoir characterization and CO2 storage qualification using advanced petrophysical, geochemical and geomechanical analysis.
- Black Sea Offshore Development AwardCore Lab secured a role supporting a major offshore operator in the Black Sea as its development project advances toward first hydrocarbon production. Core is providing an offshore mobile laboratory with on-site sampling and analytical services during start-up and initial production operations.
- Five-Year Water Shutoff ContractFollowing development and qualification of a proprietary retrievable packer combined with Core Lab's X-SPAN tubing and casing patch technology, a Southeast Asian national oil company achieved 100% operational success in an offshore water shutoff deployment. Core Lab was subsequently awarded a 5-year contract to support the operator's ongoing program.
- International Tracer Diagnostic DeploymentCore Lab deployed proprietary oil and water tracer technologies in a large-scale Middle East unconventional development. The program provided data to evaluate inter-well connectivity and completion effectiveness and will be used to optimize well spacing.
- Positive Longer-Term Industry OutlookThe IEA, EIA and OPEC anticipate strong global crude oil demand in 2027 as supply disruptions ease and trade flows normalize. Management cited natural production declines, depleted inventories and reserve-replacement needs as factors supporting investment in new resources and recovery from existing reservoirs.
- Expected Global Capital Spending IncreaseManagement said a global increase in client capital spending is emerging across conversations with its customer base, with many projects being long-cycle and not expected to be heavily influenced by short-term crude oil price fluctuations.
- Asset-Light Model and Capital DisciplineManagement reiterated its asset-light business model and stated that operational capital expenditures have historically ranged from 2% to 4% of revenue, even during periods of significant growth. Excluding U.K. facility rebuilding costs, full-year 2026 capital expenditures are expected to be $14 million to $16 million.
- Improved Inventory TurnsInventory turns improved to 2.0 from 1.8 at the end of the prior quarter, and management expects turns to gradually improve through the remainder of 2026.
MX:CLB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 2.93- | 3.95 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 3.013.01 | 4.13 | -27.27% (-1.13) | |
| Jul 29, 2026 | 2026 (Q2) | 1.632.07 | 3.57 | -42.11% (-1.50) | |
| Apr 29, 2026 | 2026 (Q1) | 1.791.13 | 2.63 | -57.14% (-1.50) | |
| Feb 04, 2026 | 2025 (Q4) | 3.593.95 | 4.13 | -4.55% (-0.19) | |
| Oct 22, 2025 | 2025 (Q3) | 3.654.13 | 4.7 | -12.00% (-0.56) | |
| Jul 23, 2025 | 2025 (Q2) | 3.503.57 | 4.13 | -13.64% (-0.56) | |
| Apr 23, 2025 | 2025 (Q1) | 2.712.63 | 3.57 | -26.32% (-0.94) | |
| Jan 29, 2025 | 2024 (Q4) | 4.124.13 | 3.57 | 15.79% (+0.56) | |
| Oct 23, 2024 | 2024 (Q3) | 4.594.70 | 4.13 | 13.64% (+0.56) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
